Encompass More Asset Management
Source: SEC Form 13F · as of Mar 2026Encompass More Asset Management holds 10 biotech & pharma companies tracked by BioSniper, totaling $3.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$3.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 2,185 | $534K |
| BBIOBridgeBio Pharma, Inc. | 6,854 | $509K |
| IBRXImmunityBio, Inc. | 57,004 | $437K |
| GILDGILEAD SCIENCES, INC. | 2,883 | $402K |
| AZNASTRAZENECA PLC | 1,422 | $280K |
| ABTABBOTT LABORATORIES | 2,536 | $260K |
| HALOHALOZYME THERAPEUTICS, INC. | 3,888 | $251K |
| ABBVAbbVie Inc. | 1,143 | $249K |
| AMGNAMGEN INC | 673 | $237K |
| MRKMerck & Co., Inc. | 1,710 | $206K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.